Inventor
BAE SUNG MIN
KR36 patents
⚠️ This page may combine multiple inventors who share the name “BAE SUNG MIN”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
HANMI PHARM IND CO LTD
16 patentsUS7737260B2Jun 15, 2010
Protein complex using an immunoglobulin fragment and method for the preparation thereof
HANMI PHARM IND CO LTD54 citations98
US9801950B2Oct 31, 2017
Liquid formulation of long acting insulinotropic peptide conjugate
HANMI PHARM IND CO LTD7 citations84
US9724420B2Aug 8, 2017
Liquid formulation of protein conjugate comprising an oxyntomodulin derivative covalently linked to a non-peptidyl polymer to an immunoglobulin FC region
HANMI PHARM IND CO LTD9 citations84
US11389508B2Jul 19, 2022
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
HANMI PHARM IND CO LTD2 citations73
US11207383B2Dec 28, 2021
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
HANMI PHARM IND CO LTD2 citations73
US10487128B2Nov 26, 2019
Conjugate of biologically active polypeptide monomer and immunoglobulin Fc fragment with reduced receptor-mediated clearance, and the method for preparing the same
HANMI PHARM IND CO LTD2 citations73
US10279041B2May 7, 2019
Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin fragment
HANMI PHARM IND CO LTD2 citations73
US9833516B2Dec 5, 2017
Liquid formulation of long-acting insulin and insulinotropic peptide
HANMI PHARM IND CO LTD5 citations73
US11603346B2Mar 14, 2023
Polyethylene glycol derivative and use thereof
HANMI PHARM IND CO LTD0 citations63
US7704709B2Apr 27, 2010
Modified human granulocyte-colony stimulating factor and process for producing same
HANMI PHARM IND CO LTD2 citations63
US11135271B2Oct 5, 2021
Glucagon derivatives with improved stability
HANMI PHARM IND CO LTD1 citations62
US11071785B2Jul 27, 2021
Liquid formulation of long-lasting protein conjugate comprising the oxyntomodulin and an immunoglobulin Fc region
HANMI PHARM IND CO LTD0 citations62
US10987424B2Apr 27, 2021
Liquid formulation of long-acting insulin conjugate
HANMI PHARM IND CO LTD1 citations62
US10987425B2Apr 27, 2021
Liquid formulation of long-acting human growth hormone immunoglobulin conjugate
HANMI PHARM IND CO LTD0 citations59
US7052867B2May 30, 2006
Expression and secretion vector for human interferon alpha and process for producing human interferon alpha by employing same
HANMI PHARM IND CO LTD4 citations59
US10441665B2Oct 15, 2019
Liquid formulation of long acting insulinotropic peptide conjugate
HANMI PHARM IND CO LTD0 citations52
HANMI SCIENCE CO LTD
5 patentsUS9981017B2May 29, 2018
Insulin conjugate using an immunoglobulin fragment
HANMI SCIENCE CO LTD4 citations70
US10071166B2Sep 11, 2018
Protein complex using an immunoglobulin fragment and method for the preparation thereof
HANMI SCIENCE CO LTD1 citations63
US11168109B2Nov 9, 2021
Process for preparation of physiologically active polypeptide complex
HANMI SCIENCE CO LTD1 citations62
US10744187B2Aug 18, 2020
Insulin conjugate using an immunoglobulin fragment
HANMI SCIENCE CO LTD1 citations61
US10064951B2Sep 4, 2018
Liquid formulation of highly concentrated long-acting human growth hormone conjugate
HANMI SCIENCE CO LTD0 citations41
HANMI PHARMACEUTICAL CO LTD
3 patentsUS12508298B2Dec 30, 2025
Protein complex by use of a specific site of an immunoglobulin fragment for linkage
HANMI PHARMACEUTICAL CO LTD0 citations62
US12139455B2Nov 12, 2024
Polyethylene glycol derivative and use thereof
HANMI PHARMACEUTICAL CO LTD0 citations62
US12274750B2Apr 15, 2025
Lyophilized formulation of long-acting human growth hormone immunoglobulin conjugate
HANMI PHARMACEUTICAL CO LTD0 citations59